Wednesday, May 23, 2012 4:14:07 AM
I doubt it. It is way too early for any pharma company to be very interested in the science, and in any case if they wanted a piece of the action they'd go to the company, not the market.
Much of the selling is almost certainly continued dumping by the shady DMBM Inc. The info statement filed a few days ago show them having being issued with 209M free trading shares at $0.0025 since November last year.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=75667992
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM